Congenital Heart Disease — Atrial Septal Defect

Left-to-Right Shunt Mechanics

• The atrial septal defect permits blood to flow from the lower-pressure left atrium into the higher-compliance right atrium during atrial filling and ventricular systole
• Because atrial pressures are lower than ventricular pressures, shunting is pressure-independent and depends on relative compliance of the right and left ventricles and pulmonary-to-systemic vascular resistance ratios
• The magnitude of shunting increases with right ventricular compliance and decreases with left ventricular compliance; thus conditions increasing LV stiffness (hypertension, left ventricular hypertrophy) reduce shunt magnitude

Progressive Volume Overload

• Chronic left-to-right shunting results in increased pulmonary blood flow (Qp:Qs ratio typically 1.5:1 to 3:1); the recirculated blood returns to the left atrium, augmenting diastolic filling of the left ventricle
• The right atrium and right ventricle dilate progressively to accommodate increased volume; right ventricular dilatation stretches the tricuspid annulus, producing functional tricuspid regurgitation
• Over decades, chronic pulmonary overcirculation leads to pulmonary vascular remodeling with medial hypertrophy, intimal fibrosis, and eventual atherosclerotic changes—the substrate for pulmonary hypertension

Rhythm Disturbances

• Right atrial dilatation disrupts the normal atrial conduction pathways and predisposes to reentrant mechanisms
• The stretched atrial tissue develops areas of slow conduction and increased automaticity, particularly around the sinus node and atrioventricular node
• These alterations explain the high prevalence of atrial fibrillation (30–50% by age 40–50) and atrial flutter in adult ASD patients

Secondary Pulmonary Hypertension (Late Stage)

• If the left-to-right shunt persists uncorrected for decades, progressive pulmonary vascular obstructive disease develops
• Sustained elevation of pulmonary blood flow causes endothelial dysfunction, loss of vasodilatory capacity, and fixed obstruction
• Eventually, pulmonary vascular resistance may equal or exceed systemic resistance, causing reversal of the shunt (Eisenmenger physiology) with cyanosis, a terminal event

Genetic & Chromosomal Factors

• Familial ASDs (autosomal dominant inheritance with variable penetrance): mutations in genes encoding transcription factors and structural proteins (e.g., NKX2-5, GATA4, CRELD1)
• Chromosome 22q11 deletion syndrome (DiGeorge syndrome): associated with sinus venosus and ostium secundum ASDs
• Down syndrome (Trisomy 21): increased incidence of ostium primum ASD as part of endocardial cushion defects
• Heterotaxy syndromes (asplenia, polysplenia): associated with complex ASDs and situs inversus totalis

Maternal & Environmental Factors

• Maternal diabetes mellitus (particularly poorly controlled gestational diabetes): increased risk of ostium primum defects
• Maternal exposure to teratogenic agents during first trimester: thalidomide, retinoic acid, phenytoin, lithium
• Advanced maternal age (>35 years): modest increased risk of aneuploidy-associated defects

Acquired Triggers (Rare)

• Endocarditis with septal perforation (extremely rare)
• Trauma with iatrogenic septal perforation (e.g., during cardiac catheterization)

Pediatric Presentation

• Most children are asymptomatic and the defect is discovered incidentally during routine examination or imaging
• Failure to thrive may occur if the shunt is large (Qp:Qs >2.5:1), though less common than with VSD
• Recurrent lower respiratory tract infections may result from increased pulmonary blood flow and pulmonary edema
• Exercise intolerance develops in childhood if significant pulmonary hypertension is present

Adult Presentation

• Dyspnea on exertion and fatigue (often attributed to deconditioning or other causes, leading to diagnostic delay)
• Palpitations and syncope (due to atrial fibrillation or flutter)
• Right heart failure symptoms: peripheral edema, elevated jugular venous pressure, hepatomegaly
• Paradoxical embolism presenting as stroke or transient ischemic attack (cryptogenic stroke in young patient should raise suspicion for PFO/ASD)

Physical Examination Findings

• Fixed splitting of the second heart sound (S2) is pathognomonic: the A2-P2 interval remains constant throughout the respiratory cycle because the increased RV stroke volume during inspiration is accommodated by the capacitance of the dilated RV rather than increasing pulmonary venous return to the left heart
• Systolic ejection murmur at the left upper sternal border (pulmonary outflow murmur due to increased pulmonary blood flow, not the defect itself—recall that ASD itself produces no murmur because shunting occurs at low-pressure atrial level)
• Diastolic flow murmur at the lower left sternal border (tricuspid flow murmur from increased RV inflow)
• Hepatomegaly and peripheral edema (right heart failure)
• Cyanosis (only if Eisenmenger physiology has developed)
• Normal single S2 (paradoxically may occur if pulmonary hypertension is severe enough to reverse the shunt direction)

12-Lead Electrocardiography

• Right axis deviation (RAD): rightward mean QRS axis due to RV dilatation and RV dominance
• First-degree AV block (prolonged PR interval): particularly common in ostium primum ASDs owing to proximity to the AV node
• Atrial fibrillation or atrial flutter: present in up to 50% of adult patients
• Incomplete right bundle branch block (rSr' pattern in V1-V2): due to RV dilatation delaying right ventricular conduction
• Axis deviation of P waves: right atrial enlargement produces peaked P waves in leads II, III, and aVF

Chest X-Radiography

• Cardiomegaly: enlargement of cardiac silhouette with prominent RV and RA
• Increased pulmonary vascular markings: representing increased pulmonary blood flow
• Prominent pulmonary artery segment on left heart border
• Straightening of the left heart border: loss of the normal concavity due to RV dilatation

Transthoracic Echocardiography (TTE)

• Saline contrast bubble study (agitated saline microbubbles): demonstrates opacification of the right heart chambers within 3–5 cardiac cycles after left heart opacification; this is the "bubble test" for right-to-left shunting
• Dilated right atrium and right ventricle: RV appears enlarged relative to LV on apical views
• Flattened or paradoxical septal motion: the interventricular septum moves anteriorly during systole (leftward or posteriorly normally) due to RV volume and pressure overload
• Pulsed and color-flow Doppler: may visualize the defect itself (particularly in ostium secundum), with left-to-right color flow across the atrial septum
• Inferior vena cava dilatation and reduced collapsibility: sign of right heart failure
• Increased left atrial volume and left ventricular diastolic dimension: due to recirculated pulmonary venous return
• Doppler estimation of PA pressure: elevated tricuspid regurgitation jet velocity (if present) suggests pulmonary hypertension

Transesophageal Echocardiography (TEE)

• Superior spatial resolution for imaging the atrial septum, particularly useful when TTE is technically limited
• Allows characterization of defect location, size, and shape—critical for intervention planning
• Can assess for associated lesions: additional ASDs, pulmonary veins, coronary sinus abnormalities
• High sensitivity and specificity (>95%) for detecting ASDs

Cardiac Catheterization

• Indicated when pulmonary hypertension is suspected or when noninvasive studies are inconclusive
• Oximetry run demonstrates a step-up in oxygen saturation at the atrial level: right atrial O2 sat >7–8% higher than superior/inferior vena cava (or IVC-to-RA step-up >5%)
• Qp:Qs calculation (pulmonary-to-systemic flow ratio): determines shunt magnitude
• Qp = (SaO2 − MvO2)/(PvO2 − PaO2) where MvO2 = mixed venous O2 sat
• Qp:Qs >1.5:1 is generally considered hemodynamically significant
• Pressures: measures right atrial, right ventricular, pulmonary artery, pulmonary capillary wedge (PCWP), left atrial, and systemic pressures
• Pulmonary vascular resistance (PVR) calculation: PVR = (mPAP − PCWP) / Qp; normal is <3 Wood units
• Identification of Eisenmenger syndrome: mPAP ≥25 mmHg at rest, PVR >3 Wood units with bidirectional or predominantly right-to-left shunt

Computed Tomography (CT) Angiography

• Useful for assessing pulmonary vasculature and determining PVR when echocardiography is inconclusive
• Can evaluate for anomalous pulmonary venous return (especially sinus venosus ASDs)
• Less commonly used than echocardiography due to radiation exposure but helpful in surgical planning

Cardiac Magnetic Resonance (CMR)

• Gold standard for measuring RV volumes and function: essential for determining optimal timing of intervention
• Superior for assessing complex anatomy, particularly partial anomalous pulmonary venous return (PAPVR)
• Allows quantification of Qp:Qs using phase-contrast flow measurements
• Useful for evaluating ventricular function in patients with suspected cardiomyopathy

Diagnostic Criteria for Hemodynamically Significant ASD

• Qp:Qs ≥1.5:1
• Right ventricular volume overload on imaging (RV end-diastolic volume >100 mL/m²)
• PA systolic pressure >50 mmHg or mPAP >25 mmHg
• PA dilatation >40 mm on imaging

Indications for Closure

• Class I (definitive benefit): Qp:Qs ≥1.5:1 AND/OR RV volume overload on imaging (RV indexed end-diastolic volume ≥60 mL/m²), regardless of symptoms
• Class IIa (reasonable benefit): Qp:Qs ≥1.5:1 AND symptoms attributable to ASD (dyspnea, exercise limitation) despite optimal medical therapy
• Class IIb (may be considered): Qp:Qs <1.5:1 with specific indications (recurrent paradoxical embolism, significant RV dilation, or pulmonary hypertension)

Percutaneous Transcatheter ASD Closure (First-Line)

• Mechanism: Device (most commonly the Amplatzer Septal Occluder, a nitinol double-disk self-expanding occluder) is positioned across the defect under fluoroscopic and/or transesophageal echocardiographic guidance, then deployed to cover the defect
• Indications:
• Ostium secundum ASDs (70% of cases)—ideal candidates
• Defect size ≤38 mm (larger defects may require surgical closure)
• Adequate septal rims (≥5 mm distance from defect edges to SVC, IVC, mitral valve, tricuspid valve, and AV valves)
• Advantages: minimally invasive, shorter hospital stay, faster recovery, lower infection risk, no surgical scar
• Success rate: >95% with low complications; complete closure achieved in >90% at 1-year follow-up
• Contraindications: active endocarditis, thrombus in RA/RV, uncontrolled systemic infection, inadequate septal rims, complex anatomy

Surgical ASD Closure (Second-Line)

• Indications:
• Ostium primum defects (require patch repair or direct suturing)
• Sinus venosus defects (require patch repair with routing of anomalous pulmonary veins)
• Secundum ASDs unsuitable for percutaneous closure (large size, inadequate rims, associated anomalies)
• Failed transcatheter closure
• Approach: typically median sternotomy with cardiopulmonary bypass; direct suturing for small defects or patch repair (autologous pericardium, synthetic fabric) for larger defects
• Success rate: >99% with low perioperative mortality (<1%) in adults; higher morbidity/mortality if significant pulmonary hypertension or advanced age
• Advantages: definitive closure, appropriate for all ASD types, can address associated lesions
• Disadvantages: surgical trauma, longer recovery, potential postoperative arrhythmias, sternotomy scar

Medical Therapy (Supportive Measures)

• No specific pharmacotherapy closes ASDs; medical management is palliative only
• Diuretics (furosemide, thiazides): reduce volume overload and manage heart failure symptoms; use cautiously as they decrease preload and may worsen symptoms
• Beta-blockers and calcium-channel blockers: manage atrial fibrillation rate and provide symptom relief; examples include metoprolol, diltiazem
• ACE inhibitors or ARBs: may reduce RV remodeling and preserve function, particularly if RV dysfunction or hypertension develops
• Anticoagulation with warfarin or DOACs: if atrial fibrillation develops to prevent cardioembolic stroke
• Endocarditis prophylaxis: NOT recommended for uncomplicated ASD (low risk); may be considered after device closure during the first 6 months

Monitoring After Closure

• Transthoracic echocardiography: at 1 month, 6 months, and 1 year to confirm complete closure and assess for residual shunting
• Electrocardiography: baseline and annual surveillance for development of atrial arrhythmias
• Holter monitoring or event monitor: if symptoms of palpitations or syncope develop
• Exercise stress testing: to assess functional capacity improvement and ischemia
• Clinical follow-up: annually with cardiology; assess for symptom improvement, arrhythmia development, and device-related complications
• Antiplatelet therapy: aspirin 81 mg daily for 6 months after transcatheter closure to reduce thrombotic risk; lifelong if device-related thrombosis risk factors present

Atrial Arrhythmias (Most Common)

• Atrial fibrillation develops in 30–50% of adults by age 40–50; characterized by rapid, irregular ventricular response and loss of atrial contribution to ventricular filling
• Management: rate control with beta-blockers or calcium-channel blockers; rhythm control (antiarrhythmics, cardioversion) reserved for symptomatic patients or those with hemodynamic compromise; antico

The buzzwords that give away the diagnosis

• Fixed split S2: the one finding examiners equate with ASD. It is fixed because the chronically volume-loaded RV already ejects a large stroke volume, so inspiratory augmentation of systemic venous return adds little further delay to P2 — and inspiratory-increased pulmonary venous return to the LA is offset by increased shunting.
• The murmur is not the shunt: flow across a low-pressure atrial communication is silent. The systolic murmur is a pulmonary outflow flow murmur and the diastolic rumble is a tricuspid flow murmur. A stem describing a "harsh holosystolic murmur at the lower left sternal border" is pointing you to VSD, not ASD.
• ECG pattern by subtype: ostium secundum classically gives right axis deviation with incomplete RBBB (rSr′ in V1); ostium primum/AV septal defect classically gives a leftward–superior axis plus first-degree AV block, reflecting displacement of the conduction axis by the endocardial cushion defect.

Associations worth memorizing

• Down syndrome → ostium primum (AV septal) defect; **Holt-Oram syndrome (TBX5) → ASD with thumb/radial ray anomalies; sinus venosus ASD → partial anomalous pulmonary venous return; ASD plus mitral stenosis → *Lutembacher syndrome***.
• Cryptogenic stroke in a young patient should prompt evaluation for an interatrial communication (paradoxical embolism); note a patent foramen ovale is a flap-valve, not a true septal deficiency, and does not cause RV volume overload.

Single best next steps

• Transthoracic echocardiography with agitated saline is the first test; TEE or cardiac MRI when the septum is poorly seen or anomalous pulmonary veins are suspected. Catheterization is reserved for suspected pulmonary hypertension per the ACC/AHA adult congenital heart disease guideline.
• Secundum defects with adequate rims → transcatheter device closure; primum and sinus venosus defects → surgical repair.

Common distractors

• Do not close an ASD once Eisenmenger physiology with fixed, severely elevated pulmonary vascular resistance is established — the shunt is the RV's pop-off valve, and closure precipitates right heart failure.
• Antibiotic endocarditis prophylaxis is not indicated for an isolated unrepaired ASD under AHA/ACC recommendations.